Saundra Homan
Family · Memphis, TNNPI 1780107219
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,258, more than ten times the $69 reported in 2021. Among family clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $31.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$654
- Lilly USA, LLC$535
- Otsuka America Pharmaceutical, Inc.$531
- Bayer$448
- Novartis$448
- AstraZeneca$423
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,03597%
- Education$1523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 18 | $654 |
| Lilly USA, LLC | 20 | $535 |
| Otsuka America Pharmaceutical, Inc. | 19 | $531 |
| Bayer | 20 | $448 |
| Novartis | 15 | $448 |
| AstraZeneca | 12 | $423 |
| Travere Therapeutics, Inc. | 9 | $329 |
| Mallinckrodt Hospital Products Inc. | 8 | $289 |
| Nxstage Medical, Inc. | 3 | $265 |
| Calliditas Therapeutics US Inc. | 7 | $239 |
| Amgen | 2 | $202 |
| Vifor Pharma, Inc. | 10 | $191 |
| Aurinia Pharma U.S., Inc. | 4 | $145 |
| Fresenius USA Marketing, Inc. | 7 | $130 |
| Novo Nordisk | 1 | $119 |
| Akebia Therapeutics Inc | 2 | $54 |
| Boehringer Ingelheim | 3 | $52 |
| OPKO Pharmaceuticals, LLC | 2 | $40 |
| Sanofi | 1 | $28 |
| Shield Therapeutics Inc | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $18 |
| GSK | 1 | $15 |
| Cormedix Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$255
- LIBERTY SELECT CYCLER$241
- NXSTAGE SYSTEM ONE$241
- FARXIGA$226
- XPHOZAH 30 MG$221
- TARPEYO$125
- Filspari$125
- Ozempic$119
- JYNARQUE$117
- LUPKYNIS$117
- Tavneos$108
How this compares
$5,187 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 58 | $49,328 |
| JardianceEmpagliflozin | 41 | $37,720 |
| Potassium Chloride | 46 | $797 |
| Losartan Potassium | 54 | $313 |
| Hydralazine Hcl | 33 | $309 |
| Olmesartan Medoxomil | 16 | $294 |
| Ciprofloxacin Hcl | 47 | $281 |
| Calcitriol | 13 | $221 |
| Allopurinol | 36 | $184 |
| Lisinopril | 14 | $175 |
| Furosemide | 46 | $162 |
| Clonidine Hcl | 13 | $112 |
| Amlodipine Besylate | 31 | $93 |
| Atorvastatin Calcium | 27 | $79 |
| Cephalexin | 17 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $423 | $49,32858 claims |
| Boehringer IngelheimJardiance | $52 | $37,72041 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.
Other family in Memphis
- Marye BernardMemphis$115K
- Brett SnodgrassMemphis$47K
- John ScallionsMemphis$30K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.